메뉴 건너뛰기




Volumn 53, Issue 5 SUPPL., 2005, Pages

Distal lower extremity paresthesia and foot drop developing during adalimumab therapy

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; METHOTREXATE; PSORALEN; STEROID;

EID: 26644456945     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.03.062     Document Type: Article
Times cited : (27)

References (16)
  • 1
    • 10944225166 scopus 로고    scopus 로고
    • Adalimumab: Human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody
    • D.E. Baker Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody Rev Gastroenterol Disord 4 2004 196 210
    • (2004) Rev Gastroenterol Disord , vol.4 , pp. 196-210
    • Baker, D.E.1
  • 2
    • 2442590862 scopus 로고    scopus 로고
    • New drugs for rheumatoid arthritis
    • N.J. Olsen, and C.M. Stein New drugs for rheumatoid arthritis N Engl J Med 350 2004 2167 2179
    • (2004) N Engl J Med , vol.350 , pp. 2167-2179
    • Olsen, N.J.1    Stein, C.M.2
  • 3
    • 4544317926 scopus 로고    scopus 로고
    • Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab
    • A.L. Chew, A. Bennett, C.H. Smith, J. Barker, and B. Kirkham Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab Br J Dermatol 151 2004 492 496
    • (2004) Br J Dermatol , vol.151 , pp. 492-496
    • Chew, A.L.1    Bennett, A.2    Smith, C.H.3    Barker, J.4    Kirkham, B.5
  • 4
    • 0035960624 scopus 로고    scopus 로고
    • Onset of multiple sclerosis associated with anti-TNF therapy
    • N.L. Sicotte, and R.R. Voskuhl Onset of multiple sclerosis associated with anti-TNF therapy Neurology 57 2001 1885 1888
    • (2001) Neurology , vol.57 , pp. 1885-1888
    • Sicotte, N.L.1    Voskuhl, R.R.2
  • 5
    • 0035674613 scopus 로고    scopus 로고
    • Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides
    • N. Mohan, E.T. Edwards, T.R. Cupps, P.J. Oliverio, G. Sandberg, and H. Crayton Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides Arthritis Rheum 44 2001 2862 2869
    • (2001) Arthritis Rheum , vol.44 , pp. 2862-2869
    • Mohan, N.1    Edwards, E.T.2    Cupps, T.R.3    Oliverio, P.J.4    Sandberg, G.5    Crayton, H.6
  • 6
    • 84855225857 scopus 로고    scopus 로고
    • Humira (adalimumab). Abbott Laboratories.
    • US Federal Drug Administration. Advisory committee briefing document. Humira (adalimumab). Abbott Laboratories. Available from: URL: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3930B1_02_A-Abbott-Humira.pdf. Accessed February 4, 2003.
    • Advisory Committee Briefing Document
  • 7
  • 8
    • 0035719745 scopus 로고    scopus 로고
    • Tumor necrosis factor and motoneuronal degeneration: An open problem
    • P. Ghezzi, and T. Mennini Tumor necrosis factor and motoneuronal degeneration: an open problem Neuroimmunomodulation 9 2001 178 182
    • (2001) Neuroimmunomodulation , vol.9 , pp. 178-182
    • Ghezzi, P.1    Mennini, T.2
  • 9
    • 3242716045 scopus 로고    scopus 로고
    • Efficacy of etanercept in the treatment of acute, severe sciatica: A pilot study
    • S. Genevay, S. Stingelin, and C. Gabay Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study Ann Rheum Dis 63 2004 1120 1123
    • (2004) Ann Rheum Dis , vol.63 , pp. 1120-1123
    • Genevay, S.1    Stingelin, S.2    Gabay, C.3
  • 10
    • 0037624699 scopus 로고    scopus 로고
    • Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy
    • R.L. Chin, W.H. Sherman, H.W. Sander, A.P. Hays, and N. Latov Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy J Neurol Sci 210 2003 19 21
    • (2003) J Neurol Sci , vol.210 , pp. 19-21
    • Chin, R.L.1    Sherman, W.H.2    Sander, H.W.3    Hays, A.P.4    Latov, N.5
  • 11
    • 0038721588 scopus 로고    scopus 로고
    • Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
    • M.H. Weisman, L.W. Moreland, D.E. Furst, M.E. Weinblatt, E.C. Keystone, and H.E. Paulus Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study Clin Ther 25 2003 1700 1721
    • (2003) Clin Ther , vol.25 , pp. 1700-1721
    • Weisman, M.H.1    Moreland, L.W.2    Furst, D.E.3    Weinblatt, M.E.4    Keystone, E.C.5    Paulus, H.E.6
  • 12
    • 0033546665 scopus 로고    scopus 로고
    • TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study; The Lenercept multiple sclerosis study group and the University of British Columbia MS/MRI analysis group
    • The Lenercept Multiple Sclerosis Study Group TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study; the Lenercept multiple sclerosis study group and the University of British Columbia MS/MRI analysis group Neurology 53 1999 457 465
    • (1999) Neurology , vol.53 , pp. 457-465
  • 13
    • 0029751983 scopus 로고    scopus 로고
    • Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
    • B.W. van Oosten, F. Barkhof, L. Truyen, J.B. Boringa, F.W. Bertelsmann, and B.M. von Blomberg Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 Neurology 47 1996 1531 1534
    • (1996) Neurology , vol.47 , pp. 1531-1534
    • Van Oosten, B.W.1    Barkhof, F.2    Truyen, L.3    Boringa, J.B.4    Bertelsmann, F.W.5    Von Blomberg, B.M.6
  • 15
    • 0025268954 scopus 로고
    • A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota
    • D.R. Wynn, M. Rodriguez, W.M. O'Fallon, and L.T. Kurland A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota Neurology 40 1990 780 786
    • (1990) Neurology , vol.40 , pp. 780-786
    • Wynn, D.R.1    Rodriguez, M.2    O'Fallon, W.M.3    Kurland, L.T.4
  • 16
    • 0035464263 scopus 로고    scopus 로고
    • Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: By what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
    • W.H. Robinson, M.C. Genovese, and L.W. Moreland Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44 2001 1977 1983
    • (2001) Arthritis Rheum , vol.44 , pp. 1977-1983
    • Robinson, W.H.1    Genovese, M.C.2    Moreland, L.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.